Up and running again

A Boston Scientific therapy helped Esther overcome cancer pain.

Read her story

Featured stories
Oct 22, 2025
Interested in our Q3 2025 earnings?

Get some key highlights of our performance this quarter.

Oct 21, 2025
Her father walked her down the aisle, thanks to her company's heart device

The WATCHMAN Left Atrial Appendage Closure device has given one employee's family more time to celebrate.

Sep 26, 2025
What is coronary artery disease and how is it treated?

CAD is the most common form of heart disease. Learn why arteries become clogged and how minimally invasive treatments can reopen them.

Read more stories

Press releases
Oct 22, 2025
Boston Scientific announces results for third quarter 2025

Boston Scientific Corporation (NYSE: BSX) generated net sales of $5.065 billion during the third quarter of 2025, growing 20.3 percent on a reported basis, 19.4 percent on an operational1 basis...

Oct 17, 2025
Boston Scientific Announces Agreement to Acquire Nalu Medical, Inc.

Acquisition to expand the neuromodulation offerings for people living with chronic pain MARLBOROUGH, Mass., Oct. 17, 2025 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced...

Sep 2, 2025
Boston Scientific announces 2025 Investor Day meeting and conference call discussing third quarter 2025 results

Boston Scientific Corporation (NYSE: BSX) will host a meeting with the investor community to review its financial goals and long-term growth strategies on Tuesday, September 30, 2025.

Read more press releases

In the news
Jun 30, 2025
3 ways AI is delivering for unmet cardiology needs
STAT (sponsored)
At STAT’s AI-focused Breakthrough Summit West, Ken Stein, MD, senior vice president and global chief medical officer, shares how artificial intelligence is helping cardiologists make the leap from available insights to actionable ones.
Jun 12, 2025
What's the secret behind Boston Scientific's successful product launches?
BioWorld
At DeviceTalks Minnesota, Ken Stein, MD, senior vice president and global chief medical officer, outlines the steps Boston Scientific takes to evaluate a market, choose a development approach and establish the groundwork for adoption.
May 29, 2025
Michael Mahoney turned Boston Scientific into a medical tech empire
Investor's Business Daily
CEO Mike Mahoney shares lessons learned over his career that helped him shape Boston Scientific's winning culture and drive the company’s growth.
May 20, 2025
Meet America’s best employers for new grads
Forbes
Lisa Considine, senior vice president of global talent, describes the professional development opportunities offered by Boston Scientific to early career talent that supports the company’s top ranking on Forbes’ list of America’s Best Employers for New Grads.

Read more news

How AI is already transforming your health care
2024 Performance Report

When science, humanity and purpose connect, lives can be transformed

View the Report

News alerts

Sign up to receive our press releases via email

Media contacts

Business and enterprise contacts for journalists

Media resources

Imagery and other resources

Top